ChromaDex Corp. announced that it has appointed Nobel Laureate Roger Kornberg to Chair the Company's newly formed Scientific Advisory Board.

ChromaDex has announced the initiation of the first human clinical study in the U.S. for PURENERGY.

For the Hain Celestial Group, a year of record sales signals a shift in consumer behavior.

Fenchem reportedly saw a 20% increase in its global sales in the first six months of 2013.